Life Science Success

In this episode of Life Science Success, my guest is Ketan Mehta, the founder and CEO of Tris Pharma. Under his leadership, Tris Pharma has developed many innovative technologies, launched new products, and established itself as a leader among technology-driven pharmaceutical companies.

• Ketan Mehta discusses the importance of being open to change and feedback in building successful companies
• Patient feedback has directly influenced Tris Pharma's product development
• Ketan Mehta believes that the pharmaceutical industry will evolve significantly in the next decade, particularly with the rise of personalized medicine and digital health
• He offers advice for aspiring entrepreneurs in the life sciences, emphasizing the need for clear motivation, commitment, and a focus on making a positive impact
• Ketan Mehta is excited about the future possibilities and the potential for significant change in the next few decades

This week on the Life Science Success podcast, my guest is Thomas Farb-Horch. Thomas is the CEO of Thrive Bio. He has been involved in the founding of 18 pharmaceutical, biotech, medtech, software, and AI companies, 7 of which have been unicorns. Currently, he is CEO and Co-Founder of Boston-based Thrive Bioscience, which commercializes instruments and software for a critically important but neglected area of life sciences, which is imaging, analytics, and automation of cell culture, cell-based research, and cell therapeutics.

• Thomas Forest Farb-Horch has experience automating cytology labs and now seeks to improve cell culture labs through Thrive.
• Thrive aims to improve the low chances of therapeutics getting from bench to patient by transforming cell biology.
• Thrive's technology collects large, comparable data sets that make better cells, which is important for bringing cell therapeutics to the market.
• Thrive's data sets and images are valuable to researchers because they can see things that they never saw before and make faster decisions.
• Thrive is transforming viral plaque assay, which is the standard way of studying viruses, and can now track plaques from day 2 instead of waiting for weeks.
• Thomas is concerned about divisiveness, duality, and false dualities, and the lack of equality of opportunity, education, and health.
• Thomas is excited about solving big, ignored problems and changing the world.

In this episode of Life Science Success, my guest is John Alderete. Dr. Alderete has successfully applied his wide range of experience and formal training to the evaluation, financing, formation, and operation of diagnostics and medical device technology companies.

• Don Davis and John Alderete discuss pitching scientific research to investors
• Davis emphasizes tailoring pitches to the audience and understanding investors' perspective
• Alderete stresses the importance of having the right team and being honest about limitations
• Alderete expresses concern about lack of progress in biological surveillance and potential for future pandemics
• Alderete is excited about modern tools and technologies available to younger generation of scientists
• The conversation offers insights on challenges of pitching research, importance of team, and need for better pandemic preparation
• It highlights exciting possibilities in modern tools and technologies for younger scientists.

In this episode of Life Science Success, my guest is Dr. Helen Torley. Dr. Torley is the President and CEO of Halozyme. Halozyme's innovative and disruptive solutions provide new therapeutic options that could significantly improve the patient experience by changing how treatments are delivered.

• Dr. Helen Torley, CEO of Halozyme, discusses the company's dedication to improving patient experiences and outcomes through their research and development of monoclonal antibodies and small molecules.
• Halozyme places a strong emphasis on corporate culture, including cross-functional collaboration and community outreach.
• Dr. Torley shares how the book "The Five Dysfunctions of a Team" has influenced her leadership style.
• Dr. Torley is inspired by the innovative ideas and enthusiasm of her team members.
• She expresses concern about the impact of remote work on creativity, problem-solving, and personal development.
• The company is focused on putting patients at the center of their mission.
• They have a strong focus on community outreach, with 70% employee participation in volunteering events.
• She shares a personal story about a family member's experience with cancer treatment to underscore the importance of improving patient experiences.
• This episode of the Life Science Success podcast provides insight into the innovative solutions Halozyme is developing and their commitment to patient-centered care.